We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

QIAGEN Achieves Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer

News   Jul 11, 2012

 
QIAGEN Achieves Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
 
 
 

RELATED ARTICLES

Sensor Could Transform Clinical Care of People with Reproductive Disorders

News

The RAPTER platform was able to detect changes in LH pulse patterns in patients with reproductive disorders, and distinguish between different patient cohorts. Unlike current methods, the test is low-cost and can provide results instantly.

READ MORE

Type 1 Diabetes Could Be Triggered by Viruses That Linger in the Gut

News

Researchers provide new evidence supporting an association between elevated levels of enteroviruses in the intestinal tracts of children and islet autoimmunity, a precursor to Type 1 diabetes.

READ MORE

A Way to Improve Cancer Immunotherapy?

News

A new study has identified a drug that potentially could make a common type of immunotherapy for cancer even more effective. The study in laboratory mice found that the drug dasatinib, which is FDA-approved to treat certain types of leukemia, greatly enhances responses to a form of immunotherapy that is used against a wide range of other cancers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE